Clinical trials
Active, not recruiting Diabetes Mellitus, Type 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 12 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gan & Lee Pharmaceuticals. | 3 |
| BrightGene Bio-Medical Technology Co., Ltd. | 2 |
| Eli Lilly and Company | 2 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| Bayer | 1 |
| Beijing Dongfang Biotech Co., Ltd. | 1 |
| CSPC Ouyi Pharmaceutical Co., Ltd. | 1 |
| Duke Kunshan University | 1 |
| Gan and Lee Pharmaceuticals, USA | 1 |
| Guangdong Raynovent Biotech Co., Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 21 |
| Obesity | 3 |
| Overweight | 3 |
| Hypertension | 2 |
| Atherosclerosis | 1 |
| Diabetic Nephropathies | 1 |
| Insulin Resistance | 1 |
| Kidney Diseases | 1 |
| Renal Insufficiency, Chronic | 1 |
| Stroke | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.